Peer review

TruBridge Awarded Peer Review Designation by Healthcare Financial Management Association

Retrieved on: 
木曜日, 5月 23, 2024

TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, recently underwent a rigorous peer review of its Medical Coding Services by the Healthcare Financial Management Association (HFMA).

Key Points: 
  • TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, recently underwent a rigorous peer review of its Medical Coding Services by the Healthcare Financial Management Association (HFMA).
  • Through intense evaluation, HFMA awarded this TruBridge solution with the “ Peer Reviewed by HFMA ®” designation.
  • The Peer Review status of the healthcare business solution and its performance claims are based on effectiveness, quality and usability, price, value, and customer and technical support.
  • "We are pleased to have TruBridge achieve the HFMA Peer Reviewed designation," said HFMA Senior Vice President Professional Practice, Richard L. Gundling, FHFMA, CMA.

New RSC Policy Briefing: “Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic”

Retrieved on: 
木曜日, 4月 11, 2024

Ottawa, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- The RSC has released its latest report titled “ Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic ."

Key Points: 
  • Ottawa, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- The RSC has released its latest report titled “ Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic ."
  • The report goes beyond preparing for the next pandemic or health emergency by outlining how to comprehensively reshape Canada’s health research system.
  • Co-Chair of the Working Group, Dr. Sharon Straus, FRSC, University of Toronto, said: “We have a chance to reshape and advance Canada’s health research system to strengthen our health systems, embed health in all policy, rebuild trust in science and improve health.
  • With input from members of the public, funders, researchers, research institution leaders, and policy and decision makers, we developed 12 actionable recommendations.

Earth Day News: Free CO2 Calculator to Help Hospital Sustainability Managers Track and Reduce Stubborn Supply Chain Emissions by Using Regulated, Reprocessed Single-Use Medical Devices from AMDR Members

Retrieved on: 
月曜日, 4月 22, 2024

The Association of Medical Device Reprocessors (AMDR), the non-profit organization that advocates for the commercial reprocessing of select “single-use” medical devices (SUDs), today released a free CO2 calculator to track emissions reductions at hospitals for each regulated reprocessed SUD used.

Key Points: 
  • The Association of Medical Device Reprocessors (AMDR), the non-profit organization that advocates for the commercial reprocessing of select “single-use” medical devices (SUDs), today released a free CO2 calculator to track emissions reductions at hospitals for each regulated reprocessed SUD used.
  • Reprocessed SUDs range from simple, non-invasive pulse oximeter sensors and surgical blades, to costly and complex electrophysiology catheters used by cardiologists.
  • The FDA and the European Medicines Agency have reviewed and cleared or allow over 300 types of “single-use” devices for commercial reprocessing by AMDR members.
  • “Reprocessed devices are the low-hanging fruit of climate change solutions for the health sector – they reduce cost, waste, and emissions – and they strengthen the supply chain.”

From shrimp Jesus to fake self-portraits, AI-generated images have become the latest form of social media spam

Retrieved on: 
木曜日, 4月 25, 2024

Like the AI image of the pope in a puffer jacket that went viral in May 2023, these AI-generated images are increasingly prevalent – and popular – on social media platforms.

Key Points: 
  • Like the AI image of the pope in a puffer jacket that went viral in May 2023, these AI-generated images are increasingly prevalent – and popular – on social media platforms.
  • Even as many of them border on the surreal, they’re often used to bait engagement from ordinary users.
  • Our findings suggest that these AI-generated images draw in users – and Facebook’s recommendation algorithm may be organically promoting these posts.

Generative AI meets scams and spam

  • They’ve targeted senior citizens while posing as Medicare representatives or computer technicians.
  • On social media, profiteers have used clickbait articles to drive users to ad-laden websites.
  • This signals to the algorithmic curators that perhaps the content should be pushed into the feeds of even more people.
  • But more ordinary creators capitalized on the engagement of AI-generated images, too, without obviously violating platform policies.

Rate ‘my’ work!

  • Some of the copypasta captions baited interaction by directly asking users to, for instance, rate a “painting” by a first-time artist – even when the image was generated by AI – or to wish an elderly person a happy birthday.
  • Facebook users often replied to AI-generated images with comments of encouragement and congratulations

Algorithms push AI-generated content

  • We analyzed Facebook’s own “Widely Viewed Content Reports,” which lists the most popular content, domains, links, pages and posts on the platform per quarter.
  • It showed that the proportion of content that users saw from pages and people they don’t follow steadily increased between 2021 and 2023.
  • Changes to the algorithm have allowed more room for AI-generated content to be organically recommended without prior engagement – perhaps explaining our experiences and those of other users.

‘This post was brought to you by AI’

  • Since Meta currently does not flag AI-generated content by default, we sometimes observed users warning others about scams or spam AI content with infographics.
  • Meta, however, seems to be aware of potential issues if AI-generated content blends into the information environment without notice.
  • The company has released several announcements about how it plans to deal with AI-generated content.
  • In May 2024, Facebook will begin applying a “Made with AI” label to content it can reliably detect as synthetic.


The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Dr. Aysun Alagoz Exposes Corrupt U.S. Healthcare Practice in Fearless Memoir - Sham Peer Reviews Ignore Due Process, Threaten Patient Safety, and Destroy Physician Careers

Retrieved on: 
月曜日, 4月 8, 2024

SAN ANTONIO, April 8, 2024 /PRNewswire/ -- During one routine Monday morning in the middle of May, 2011, OB/GYN Dr. Aysun Alagoz had no idea that her entire career and private practice were about to be upended. At odds with a powerful hospital administrator who branded Dr. Alagoz a "Disruptive Physician," she became the target for a common and often shady practice used by hospitals: the Peer Review. 

Key Points: 
  • At odds with a powerful hospital administrator who branded Dr. Alagoz a "Disruptive Physician," she became the target for a common and often shady practice used by hospitals: the Peer Review.
  • But used punitively, in a process called a Sham Peer Review, it can be leveraged to fire physicians, install handpicked cronies, leave patients stranded, and save hospitals money.
  • "The Sham Peer Review is an open, dirty secret in the U.S. healthcare system," said Dr. Alagoz.
  • The Sham Peer Reviews used by many hospital administrators and boards to remove any doctor they don't like, or disagree with, or as a way to save healthcare corporations money."

Hicks Thomas Attorneys Earn Texas Rising Stars Honors

Retrieved on: 
木曜日, 3月 21, 2024

Hicks Thomas is pleased to announce that partner Colin Watterson and senior counsel Allison Fisher have been named to Super Lawyers' 2024 list of Texas Rising Stars.

Key Points: 
  • Hicks Thomas is pleased to announce that partner Colin Watterson and senior counsel Allison Fisher have been named to Super Lawyers' 2024 list of Texas Rising Stars.
  • The attorneys are among 2.5% of eligible lawyers in the state to receive the award.
  • Their hard work and contributions have had a positive impact on our clients and our firm,” said Hicks Thomas partner John B. Thomas .
  • Texas Rising Stars honorees are attorneys 40 years or younger or who have been in practice for 10 years or less.

Fears Law Founder Earns National Recognition in Lawdragon 500 Leading Plaintiff Consumer Lawyers in America Guide

Retrieved on: 
木曜日, 3月 14, 2024

Fears Law , a national law firm based in Dallas, proudly announces the selection of firm founder Bryan Fears to the 2024 edition of the Lawdragon 500 Leading Plaintiff Consumer Lawyers in America.

Key Points: 
  • Fears Law , a national law firm based in Dallas, proudly announces the selection of firm founder Bryan Fears to the 2024 edition of the Lawdragon 500 Leading Plaintiff Consumer Lawyers in America.
  • “At Fears Law, we are committed to helping our clients navigate the complex legal system while providing exceptional service,” said Mr.
  • Fears.
  • Selections for the Lawdragon 500 Leading Plaintiff Consumer Lawyers in America are made based on a combination of industry analysis, nominations and peer review.

Three PMR Attorneys Included on List of Nation’s Top Plaintiff Lawyers

Retrieved on: 
水曜日, 3月 13, 2024

Paranjpe Mahadass Ruemke LLP, or PMR Law, is pleased to announce that Lawdragon has honored three of the firm’s attorneys in its 500 Leading Plaintiff Consumer Lawyers guide for 2024.

Key Points: 
  • Paranjpe Mahadass Ruemke LLP, or PMR Law, is pleased to announce that Lawdragon has honored three of the firm’s attorneys in its 500 Leading Plaintiff Consumer Lawyers guide for 2024.
  • Both are consistently honored for plaintiffs work by The Best Lawyers in America and Texas Super Lawyers, published by Thomson Reuters.
  • Texas Lawyer magazine has ranked PMR Law among Houston’s best personal injury firms for two consecutive years in its “Best of” listing.
  • PMR Law’s priority is to provide personalized attention, professionalism and tireless representation.

Emperion Finalizes Creation of Stand-Alone IME Business

Retrieved on: 
水曜日, 4月 3, 2024

WAYNE, Pa., April 3, 2024 /PRNewswire/ -- Emperion and Enlyte leaders have completed the separation of IME, Peer Review (PR), and Independent Review Organization (IRO) services from Enlyte to Emperion, following the agreement announced in February. Emperion will focus on expanded product development and investment opportunities for these and related solutions.

Key Points: 
  • WAYNE, Pa., April 3, 2024 /PRNewswire/ -- Emperion and Enlyte leaders have completed the separation of IME, Peer Review (PR), and Independent Review Organization (IRO) services from Enlyte to Emperion, following the agreement announced in February.
  • Emperion will focus on expanded product development and investment opportunities for these and related solutions.
  • The current IME and Peer Review business includes a network of more than 25,000 providers nationally across a broad range of medical specialties.
  • As part of the transition, Emperion will benefit from a number of key leaders who ran this business at Enlyte including Randy McKinney, SVP, IME Operations, Joe Weitzman, SVP/Chief Information Officer and Dan Riley, VP of Finance.

Union procedure on the preparation, conduct and reporting of EU pharmacovigilance inspections

Retrieved on: 
水曜日, 4月 3, 2024

Union procedure on the preparation, conduct and

Key Points: 
    • Union procedure on the preparation, conduct and
      reporting of EU pharmacovigilance inspections
      Table of contents
      1.
    • Record management and archiving ....................................................................... 12

      References ................................................................................................ 12
      Appendix 1 ?Pharmacovigilance inspection report .................................... 13
      Appendix 2- Inspection overview (IO) ...................................................... 14
      Appendix 3- Pharmacovigilance inspection outcome sharing .................... 15
      Appendix 4- Classification of inspection findings....................................... 16

      Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 2/16

      1.

    • Guidelines on the interpretation of legislative pharmacovigilance
      requirements are published in the adopted good pharmacovigilance practices (GVPs) Module III ?
      pharmacovigilance inspections.
    • Preparation of a risk-based programme for pharmacovigilance inspections is presented in the Union
      procedure on the coordination of EU pharmacovigilance inspections.
    • Scope
      This procedure constitutes a guideline in preparing, conducting and reporting national competent
      authority (NCA) pharmacovigilance inspections and outlines the steps taken of the Committee for
      Medicinal Products for Human Use (CHMP) requested pharmacovigilance inspections.
    • Those are covered under the Union procedure on the
      management of pharmacovigilance inspection findings which may impact the robustness of the benefitrisk profile of the concerned medicinal products.
    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 3/16

      3.

    • Preparation
      Preparation encompasses those activities undertaken after the selection of an MAH, or third party, for
      a pharmacovigilance inspection and prior to inspection conduct.
    • For the selection of involved
      parties for CHMP requested inspections, refer to the Union procedure on the coordination of EU
      pharmacovigilance inspections.
    • Announcement communications could include, for example, the

      Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 4/16

      name of the inspector(s), MAH, the objectives and nature of the inspection (i.e.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 5/16

      ?

      Feedback from other competent authority functions, in particular pharmacovigilance assessors.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 6/16

      ?

      If teleconference(s) are planned during the inspection with experts, assessors, MAH personnel
      located off site etc.

    • ?

      Union procedure on the management of pharmacovigilance inspection findings which may impact
      the robustness of the benefit-risk profile of the concerned medicinal products.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 12/16

      Appendix 1 ?Pharmacovigilance inspection report
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 13/16

      Appendix 2- Inspection overview (IO)
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 14/16

      Appendix 3- Pharmacovigilance inspection outcome sharing
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 16/16